“58,000 rupees to predict diseases”: The bold stadium on the start of the Shark Tank India 4 does not get “reliability”

Shark Tank India recently shared three founders from Kerala and Andra Pradesh, who claimed that their invention could predict cancer and heart disease. Dr. Rajasekhara Reddy Ravuri, Dhaneesh Jameson and Tony Jose developed their company, Sugarstings.AI, which offers DNA healthy offers. Their genetic test, which is supported by machine learning, aims to discover diseases caused by genetic mutations. The trio sought 1 rupees for 2.5 % of the shares, which evaluates their company with 40 rupees.

The founders emphasized that although similar products are only 40 % accuracy, they are more accurate. However, some of their most daring claims in the television ring have been reduced. However, the stadium left the sharks surprised.

They claimed that their product can determine the genetic signs associated with cancer and heart issues, which may expect these cases years ago. Ikewal, the founding founder, was clearly surprised by these phrases.

Since its launch six months ago, only 32 units have sold. Among them, four customers have been marked with potential cancer risk – although the founders admitted that their predictions could not be confirmed unless these individuals are later diagnosed. The test costs $ 58,000, and when they were asked about his operation, they made it clear that customers should take the test themselves after receiving it by Course. This shocked Al -Azhar, who argued that such an expensive test should come with professional help.

Gupta Aman raised concerns about accuracy, especially in a country that many people lack. “Samajh Nahi Aa Raha Ki Yeh Genuine Hoga Ya Nahi Hoga,” he said, asking about the reliability of predictions. It is also concerned about the wrong positives. “Miri Tu Tendagi Khayab is Jayji (my life will end),” he said.

Vineeta Singh noted that although the test was not unreasonable for some, there was no evidence that he had already succeeded. Retich Agarawal chanted this anxiety, noting that technology was still in its early stages in India. Azhar emphasized that any dangerous medical innovation must have credible research they support – but the founders have failed to provide any scientific evidence.

Konal Bah saw the potential in this concept, but he was not convinced that he was ready to work. In the end, none of the sharks made an offer, and the founders searched without a deal.